Scheduled Maintenance Notice
Please note that Researcher Profiles will be undergoing scheduled maintenance on Wednesday 7th Oct, from 8:00am to 9:00am. During this time, the Researcher Profiles system will be unavailable. We apologise for any inconvenience and appreciate your understanding.
Select Publications
Conference Papers
, 2024, 'Real-world utilisation and switching between Janus kinase inhibitors in Australian patients with rheumatoid arthritis in the OPAL Dataset', in Clinical and Experimental Rheumatology, pp. 1763 - 1772, http://dx.doi.org/10.55563/clinexprheumatol/n0kjax
, 2024, 'POS0249 ASSOCIATIONS BETWEEN CLINICAL CHARACTERISTICS AND SCREENING MRI FINDINGS: EXPLORATORY ANALYSIS OF THE ONGOING PHASE 4, MULTICENTER, RANDOMIZED, CONTROLLED STAR STUDY OF BIOLOGIC-NAÏVE PATIENTS WITH PsA WITH MRI-CONFIRMED AXIAL INVOLVEMENT', in Annals of the Rheumatic Diseases, Elsevier, pp. 372, http://dx.doi.org/10.1136/annrheumdis-2024-eular.339
, 2023, 'Efficacy of Guselkumab in Three Cohorts of Biologic-Naive PsA Patients With Axial Involvement Defined Based on Imaging and Machine Learning Criteria: Pooled Analysis of Two Phase 3 Studies', in JOURNAL OF RHEUMATOLOGY, J RHEUMATOL PUBL CO, pp. 78 - 79
, 2023, 'Time to Achieve Minimal Disease Activity for Ixekizumab Versus Adalimumab in Patients With Psoriatic Arthritis: Posthoc Analysis of SPIRIT-H2H', in JOURNAL OF RHEUMATOLOGY, J RHEUMATOL PUBL CO, pp. 30 - 31
, 2023, 'BIMEKIZUMAB IMPROVED KEY PATIENT-REPORTED SYMPTOMS OF AXIAL SPONDYLOARTHRITIS INCLUDING SPINAL PAIN AND FATIGUE: RESULTS FROM TWO PHASE 3 STUDIES', in INTERNAL MEDICINE JOURNAL, WILEY, pp. 24 - 25
, 2023, 'BIOSIMILARS IN AUSTRALIA', in INTERNAL MEDICINE JOURNAL, WILEY, pp. 55 - 55
, 2023, 'EFFICACY AND IMPROVEMENT IN PATIENT-REPORTED OUTCOMES AT WEEKS 16 AND 52 IN IXEKIZUMAB TREATED BIOLOGICAL NAIVE PATIENTS WITH RADIOGRAPHIC AXIAL SPONDYLOARTHRITIS ACHIEVING CLINICALLY IMPORTANT PAIN AT NIGHT REDUCTION AT WEEK 16: RESULTS FROM COAST-V TRIAL', in INTERNAL MEDICINE JOURNAL, WILEY, pp. 38 - 38
, 2023, 'EMULATING A TARGET TRIAL OF ADALIMUMAB VERSUS TOFACITINIB: A COMPARATIVE EFFECTIVENESS ANALYSIS USING THE OPAL REAL-WORLD DATASET', in INTERNAL MEDICINE JOURNAL, WILEY, pp. 28 - 29
, 2023, 'REAL-WORLD UTILISATION AND SWITCHING BETWEEN JANUS KINASE INHIBITORS IN PATIENTS WITH RHEUMATOID ARTHRITIS IN THE AUSTRALIAN OPAL DATASET', in INTERNAL MEDICINE JOURNAL, WILEY, pp. 36 - 36
, 2023, 'RECAPTURE RATES WITH IXEKIZUMAB AFTER WITHDRAWAL OF THERAPY IN PATIENTS WITH AXIAL SPONDYLOARTHRITIS: RESULTS AT WEEK 104 FROM A RANDOMIZED PLACEBO-CONTROLLED WITHDRAWAL STUDY', in INTERNAL MEDICINE JOURNAL, WILEY, pp. 37 - 38
, 2023, 'SAFETY AND EFFICACY OF IXEKIZUMAB TREATMENT IN PATIENTS WITH AXIAL SPONDYLOARTHRITIS: 3-YEAR RESULTS FROM THE COAST PROGRAMME', in INTERNAL MEDICINE JOURNAL, WILEY, pp. 37 - 37
, 2022, 'A Double-Blind, Placebo-Controlled, Ascending Dose Phase 2a Study of ABP-671, a Novel, Potent and Selective URAT1 Inhibitor, in Patients with Gout or Hyperuricemia', in ARTHRITIS & RHEUMATOLOGY, WILEY, PA, Philadelphia, pp. 3601 - 3603, presented at Annual Meeting of the American-College-of-Rheumatology (ACR), PA, Philadelphia, 10 November 2022 - 14 November 2022
, 2022, 'Consistent Long-Term Guselkumab Efficacy Across Psoriatic Arthritis Domains Irrespective of Baseline Patient Characteristics', in ARTHRITIS & RHEUMATOLOGY, WILEY, PA, Philadelphia, pp. 4216 - 4218, presented at Annual Meeting of the American-College-of-Rheumatology (ACR), PA, Philadelphia, 10 November 2022 - 14 November 2022
, 2022, 'Efficacy of Guselkumab in Three Cohorts of Biologic-Naive PsA Patients with Axial Involvement Defined Based on Imaging and Machine-Learning Criteria: Pooled Analysis of Two Phase 3 Studies', in ARTHRITIS & RHEUMATOLOGY, WILEY, PA, Philadelphia, pp. 2053 - 2056, presented at Annual Meeting of the American-College-of-Rheumatology (ACR), PA, Philadelphia, 10 November 2022 - 14 November 2022
, 2022, 'A PHASE 4, LONGITUDINAL, SINGLE-ARM, OPEN-LABEL TREATMENT STUDY OF SUBCUTANEOUS GOLIMUMAB EFFECTIVENESS ASSESSED BY BOTH SPEED OF MAGNETIC RESONANCE IMAGING (MRI) CHANGES IN THE HAND/WRIST AND CLINICAL RESPONSE OUTCOMES IN PATIENTS WITH RHEUMATOID ARTHRITIS', in INTERNAL MEDICINE JOURNAL, WILEY, pp. 22 - 22
, 2022, 'IXEKIZUMAB SHOWS A PATTERN OF PAIN IMPROVEMENT IN PATIENTS WITH AND WITHOUT MEASURABLE INFLAMMATION IN PSORIATIC ARTHRITIS', in INTERNAL MEDICINE JOURNAL, WILEY, pp. 32 - 32
, 2022, 'USABILITY AND ACCEPTABILITY OF A NEW AUTOINJECTOR DEVICE AND ITS ASSOCIATED APP IN AUSTRALIAN RHEUMATOLOGY PATIENTS', in INTERNAL MEDICINE JOURNAL, WILEY, pp. 24 - 25
, 2021, 'The OMERACT Knee Inflammation MRI Scoring System: Validation of Quantitative Methodologies and Tri-compartmental Overlays by Comparison with the MRI Osteoarthritis Knee Score', in ARTHRITIS & RHEUMATOLOGY, WILEY, ELECTR NETWORK, pp. 432 - 434, presented at ACR Convergence Conference, ELECTR NETWORK, 05 November 2021 - 09 November 2021
, 2021, 'P178 The impact of peripheral articular manifestations on the efficacy of ixekizumab in patients with radiographic axial spondyloarthritis', in Rheumatology, Oxford University Press (OUP), pp. keab247.173, http://dx.doi.org/10.1093/rheumatology/keab247.173
, 2021, 'EFFICACY OF BARICITINIB IN PATIENTS WITH MODERATE-TO-SEVERE RHEUMATOID ARTHRITIS WITH 3 YEARS OF TREATMENT: RESULTS FROM A LONG-TERM STUDY', in INTERNAL MEDICINE JOURNAL, WILEY, pp. 23 - 23
, 2021, 'RENAL FUNCTION IN PATIENTS WITH RHEUMATOID ARTHRITIS RECEIVING BIOLOGIC OR TARGETED SYNTHETIC DISEASE MODIFYING ANTIRHEUMATIC DRUGS WITHIN THE AUSTRALIAN OPAL DATASET', in INTERNAL MEDICINE JOURNAL, WILEY, pp. 27 - 27
, 2021, 'SAFETY PROFILE OF BARICITINIB FOR THE TREATMENT OF RHEUMATOID ARTHRITIS UP TO 8.4 YEARS: AN UPDATED INTEGRATED SAFETY ANALYSIS', in INTERNAL MEDICINE JOURNAL, WILEY, pp. 24 - 24
, 2020, 'Efficacy of Filgotinib in Patients with Rheumatoid Arthritis with Poor Prognostic Factors: Post Hoc Analysis', in ARTHRITIS & RHEUMATOLOGY, WILEY, ELECTR NETWORK, presented at Annual Meeting of the American-College-of-Rheumatology (ACR), ELECTR NETWORK, 05 November 2020 - 09 November 2020
, 2020, 'Role of Artificial Intelligence in Assessment of Peripheral Joint MRI in Inflammatory Arthritis: A Systematic Review and Meta-analysis', in ARTHRITIS & RHEUMATOLOGY, WILEY, ELECTR NETWORK, presented at Annual Meeting of the American-College-of-Rheumatology (ACR), ELECTR NETWORK, 05 November 2020 - 09 November 2020
, 2020, 'Efficacy of Filgotinib in Patients with Rheumatoid Arthritis with Poor Prognostic Factors: Post Hoc Analysis of FINCH 3', in SWISS MEDICAL WEEKLY, E M H SWISS MEDICAL PUBLISHERS LTD, pp. 9S - 10S
, 2020, 'IXEKIZUMAB SIGNIFICANTLY IMPROVES SIGNS, SYMPTOMS AND SPINAL INFLAMMATION OF ACTIVE ANKYLOSING SPONDYLITIS/RADIOGRAPHIC AXIAL SPONDYLOARTHRITIS: 16-WEEK RESULTS OF A PHASE 3 RANDOMIZED, ACTIVE AND PLACEBO-CONTROLLED TRIAL', in INTERNAL MEDICINE JOURNAL, WILEY, pp. 12 - 13
, 2020, 'THU0188 EFFICACY OF FILGOTINIB IN PATIENTS WITH RHEUMATOID ARTHRITIS WITH POOR PROGNOSTIC FACTORS: POST HOC ANALYSIS OF FINCH 3', in Annals of the Rheumatic Diseases, Elsevier, pp. 312 - 313, http://dx.doi.org/10.1136/annrheumdis-2020-eular.288
, 2019, 'Evaluation of Effectiveness and Usage Patterns of Tofacitinib in Treatment of Rheumatoid Arthritis in Australia: An Analysis from the OPAL-QUMI Real World Dataset', in ARTHRITIS & RHEUMATOLOGY, WILEY, GA, Atlanta, presented at Annual Meeting of the American-College-of-Rheumatology/Association-of-Rheumatology-Professionals (ACR/ARP), GA, Atlanta, 08 November 2019 - 13 November 2019
, 2019, 'Novel Computer Assisted Methodology for Quantitative Assessment of MRI Treatment Responses to Apremilast in Patients with Psoriatic Arthritis', in ARTHRITIS & RHEUMATOLOGY, WILEY, GA, Atlanta, presented at Annual Meeting of the American-College-of-Rheumatology/Association-of-Rheumatology-Professionals (ACR/ARP), GA, Atlanta, 08 November 2019 - 13 November 2019
, 2019, 'Ixekizumab significantly improves signs, symptoms and spinal inflammation of active ankylosing spondylitis/radiographic axial spondyloarthritis: 16-week results of a phase 3 randomised, active and placebo-controlled trial', in SWISS MEDICAL WEEKLY, E M H SWISS MEDICAL PUBLISHERS LTD, pp. 16S - 17S
, 2019, 'Tofacitinib 5 mg Twice Daily in Patients with Rheumatoid Arthritis and Inadequate Response to Disease-Modifying Antirheumatic Drugs: A Comprehensive Review of Phase 3 Efficacy and Safety', in Journal of Clinical Rheumatology, pp. 115 - 126, http://dx.doi.org/10.1097/RHU.0000000000000786
, 2019, 'FRI0140 EVALUATION OF EFFECTIVENESS AND USAGE PATTERNS OF TOFACITINIB IN TREATMENT OF RHEUMATOID ARTHRITIS IN AUSTRALIA: AN ANALYSIS FROM THE OPAL-QUMI REAL WORLD DATASET', in Annals of the Rheumatic Diseases, Elsevier, pp. 740 - 741, http://dx.doi.org/10.1136/annrheumdis-2019-eular.5216
, 2018, 'Development and Preliminary Validation of an Omeract Magnetic Resonance Imaging (MRI) Scoring System for Ankle Enthesitis in Spondyloarthritis', in ARTHRITIS & RHEUMATOLOGY, WILEY, IL, Chicago, presented at Annual Meeting of the American-College-of-Rheumatology (ACR) and Association-for-Rheumatology-Health-Professionals (ARHP), IL, Chicago, 19 October 2018 - 24 October 2018
, 2018, 'Validity and Responsiveness of Inflammation and Joint Damage Scores Based on the Omeract Rheumatoid Arthritis MRI Scoring System', in ARTHRITIS & RHEUMATOLOGY, WILEY, IL, Chicago, presented at Annual Meeting of the American-College-of-Rheumatology (ACR) and Association-for-Rheumatology-Health-Professionals (ARHP), IL, Chicago, 19 October 2018 - 24 October 2018
, 2018, 'SUMMARY OF BARICITINIB EFFECT ON PATIENT-REPORTED OUTCOMES (PROS) IN METHOTREXATE-INADEQUATE RESPONDER PATIENT POPULATION', in RHEUMATOLOGY, OXFORD UNIV PRESS, ENGLAND, Liverpool, presented at Annual Conference of the British-Society-for-Rheumatology, ENGLAND, Liverpool, 01 May 2018 - 03 May 2018
, 2018, 'AB0905 Long-term (5-YEAR) efficacy and safety of apremilast monotherapy in dmard-naÏve subjects with active psoriatic arthritis', in Annals of the Rheumatic Diseases, Elsevier, pp. 1576 - 1577, http://dx.doi.org/10.1136/annrheumdis-2018-eular.3113
, 2018, 'AB1175 Development and preliminary validation of an omeract mri enthesitis scoring system for the ankle in spondyloarthritis', in Annals of the Rheumatic Diseases, Elsevier, pp. 1690, http://dx.doi.org/10.1136/annrheumdis-2018-eular.5000
, 2018, 'FRI0597 Validation of web-based calibration modules for imaging scoring systems based on principles of artificial intelligence: the sparcc mri sacroiliac joint inflammation score', in Annals of the Rheumatic Diseases, Elsevier, pp. 822, http://dx.doi.org/10.1136/annrheumdis-2018-eular.6880
, 2018, 'REASONS FOR BDMARD CESSATION AND SUBSEQUENT PERSISTENCE OF SECOND LINE TREATMENT IN A LARGE REAL WORLD RHEUMATOID ARTHRITIS (RA) REGISTRY', in INTERNAL MEDICINE JOURNAL, WILEY, pp. 20 - 20
, 2018, 'SAT0165 Reasons for bdmard cessation and subsequent persistence of second line treatment in a large real world rheumatoid arthritis registry', in Annals of the Rheumatic Diseases, Elsevier, pp. 943, http://dx.doi.org/10.1136/annrheumdis-2018-eular.6022
, 2018, 'SAT0671 Initial development of a whole-body magnetic resonance imaging inflammation index for active disease of peripheral joints and entheses in patients with inflammatory arthritis', in Annals of the Rheumatic Diseases, Elsevier, pp. 1183 - 1184, http://dx.doi.org/10.1136/annrheumdis-2018-eular.6191
, 2018, 'SUMMARY OF BARICITINIB EFFECT ON PATIENT-REPORTED OUTCOMES (PROS) IN METHOTREXATE-INADEQUATE RESPONDER PATIENT POPULATION', in INTERNAL MEDICINE JOURNAL, WILEY, pp. 42 - 43
, 2018, 'Summary of baricitinib effect on patient-reported outcomes in a methotrexate-inadequate responder patient population', in SCANDINAVIAN JOURNAL OF RHEUMATOLOGY, TAYLOR & FRANCIS LTD, pp. 30 - 31
, 2017, 'Fatigue, Poor Health and Mood Disturbance Persist in Rheumatoid Arthritis and Psoriatic Arthritis Patients Despite Disease Remission: The OPAL Deeper Study', in ARTHRITIS & RHEUMATOLOGY, WILEY, CA, San Diego, presented at 81st Annual Meeting of the American-College-of-Rheumatology (ACR) / Association-of-Rheumatology-Health-Professionals (ARHP), CA, San Diego, 03 November 2017 - 08 November 2017
, 2017, 'Long-Term (4-Year) Efficacy and Safety of Apremilast Monotherapy in DMARD-Naive Subjects with Active Psoriatic Arthritis', in ARTHRITIS & RHEUMATOLOGY, WILEY, CA, San Diego, presented at 81st Annual Meeting of the American-College-of-Rheumatology (ACR) / Association-of-Rheumatology-Health-Professionals (ARHP), CA, San Diego, 03 November 2017 - 08 November 2017
, 2017, 'TREATMENT PATTERNS AMONG PATIENTS WITH RHEUMATIC DISEASE (RHEUMATOID ARTHRITIS (RA), ANKYLOSING SPONDYLITIS (AS) AND PSORIATIC ARTHRITIS (PSA)) TREATED WITH SUBCUTANEOUS TNF-ALPHA ANTAGONISTS', in INTERNAL MEDICINE JOURNAL, WILEY, pp. 33 - 33, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000400304400097&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
, 2017, 'A RANDOMISED DOUBLE-BLIND PLACE-BOCONTROLLED CROSSOVER TRIAL OF ADALIMUMAB FOR EROSIVE HAND OSTEOARTHRITIS: THE HUMOR TRIAL', in OSTEOPOROSIS INTERNATIONAL, SPRINGER LONDON LTD, ITALY, Florence, pp. S59 - S59, presented at WCO-IOF-ESCEO World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases, ITALY, Florence, 23 March 2017 - 26 March 2017
, 2017, 'Apremilast, an oral phosphodiesterase 4 inhibitor, is associated with long-term (104-week) improvement in fatigue in patients with psoriatic arthritis: Pooled results from 3 phase III, randomized, controlled trials', in JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, MOSBY-ELSEVIER, FL, Orlando, pp. AB47 - AB47, presented at Annual Meeting of the American-Academy-of-Dermatology, FL, Orlando, 03 March 2017 - 07 March 2017, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000403369300182&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
, 2017, 'A STUDY OF VAGUS NERVE STIMULATION FOR RHEUMATOID ARTHRITIS', in INTERNAL MEDICINE JOURNAL, WILEY, pp. 27 - 27
, 2017, 'FRI0629 Magnetic resonance imaging (MRI) inflammation of the feet demonstrates subclinical inflammatory disease in cutaneous psoriasis patients without clinical arthritis', in Annals of the Rheumatic Diseases, Elsevier, pp. 727, http://dx.doi.org/10.1136/annrheumdis-2017-eular.5705